O'Shaughnessy Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,635	Closed	-$305K	–	1816
2023 Q3	$305K	Buy	+2,635	New	+$283K	﹤0.01%	1107
2021 Q4	–	Sell	-1,817	Closed	-$199K	–	2819
2021 Q3	$199K	Sell	1,817 -865	-32%	-$89.8K	﹤0.01%	1049
2021 Q2	$251K	Sell	2,682 -2,970	-53%	-$273K	0.01%	922
2021 Q1	$520K	Sell	5,652 -1,214	-18%	-$102K	0.01%	600
2020 Q4	$502K	Sell	6,866 -22,426	-77%	-$1.67M	0.01%	512
2020 Q3	$2.28M	Buy	29,292 +9,224	+46%	+$635K	0.07%	165
2020 Q2	$1.12M	Buy	20,068 +19,608	+4,263%	+$839K	0.03%	245
2020 Q1	$14K	Sell	460 -31,966	-99%	-$1.08M	﹤0.01%	988
2019 Q4	$1.17M	Sell	32,426 -26,580	-45%	-$815K	0.03%	252
2019 Q3	$1.61M	Sell	59,006 -15,291	-21%	-$395K	0.04%	207
2019 Q2	$1.78M	Sell	74,297 -6,557	-8%	-$166K	0.04%	204
2019 Q1	$2.13M	Buy	80,854 +60,617	+300%	+$1.44M	0.05%	187
2018 Q4	$396K	Buy	+20,237	New	+$397K	0.01%	371

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

O'Shaughnessy Asset Management's HZNP Position: Q4 2023 in Review

O'Shaughnessy Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,635 shares — an estimated $305K sold.

O'Shaughnessy Asset Management first reported a position in HZNP in Q4 2018 and held it in 13 quarters. The position peaked at $2.28M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

O'Shaughnessy Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
O'Shaughnessy Asset Management sold 2,635 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $305K.
O'Shaughnessy Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 13 quarters.
O'Shaughnessy Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.28M in Q3 2020.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.